| Across |
| 1. | caused by pollen or a foreign substance |
| 4. | acute inflammation of the mucous membranes of the nose |
| 5. | progressive lung disease caused by cigarettes, atomospheric contaminants, or lack of alpha 1 protein |
| 6. | COPD characterized by period of bronchospasm resulting in wheezing and difficulty breathing |
| 7. | a schedule II narcotic antitussive |
| 10. | used if asthma is unresponsive to bronchodilator therapy |
| 14. | inflammation of the throat or sore throat |
| 15. | a second generation antihistamine used for allergic rhinitis and urticaria with few anticholinergic effects |
| 17. | inflammation of the mucous membranes of the maxillary, frontal, ethmoid, etc |
| 21. | do not confuse this drug with atrovent |
| 22. | may increase the effect of the theophylline group and cause toxcity |
| 23. | a chemical mediator that can cause inflammatory changes in the lung |
| 24. | inflammatory disorder of teh airway walls triggered by stress, allergens, and pollutants. |
| 25. | drowsiness is a major side effect of this type of drug |
| 26. | suppresses the cough reflex |
| 27. | lung tissue is exposed to extrinsic or intrinsic factors that stimulate a bronchoconstrictive response |
| 28. | increases the level of CAMP resulting in bronchodilation |